HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic

AIDS Patient Care and STDs

Volumn 26, Issue 4, 2012, Pages 222-233

  Khawcharoenporn, Thana ^a,b,d   Kendrick, Sabrina ^a,b,c   Smith, Kimberly ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Ruth M Rothstein CORE Center   (United States)

^c Jr Hospital of Cook County   (United States)

^d THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CONDOM; EDUCATIONAL STATUS; FEMALE; HETEROSEXUALITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREEXPOSURE PROPHYLAXIS; SAFE SEX; VIRUS TRANSMISSION;

ADULT; AMBULATORY CARE FACILITIES; CONDOMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROSEXUALITY; HIV SEROPOSITIVITY; HUMANS; MALE; PRIMARY PREVENTION; RISK FACTORS; RISK-TAKING; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; SOCIAL PERCEPTION; UNITED STATES; UNSAFE SEX;

EID: 84859334002     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0202     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. HIV in the United States July 2010. www.cdc.gov/hiv/resources/factsheets/PDF/us.pdf (Last accessed September 10, 2011).
2. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance United States, 2009. MMWR Surveill Summ 2010;59:1-142.
3. Hallfors DD, Iritani BJ, MillerWC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: The need for new directions. Am J Public Health 2007;97:125-132. (Pubitemid 46067694)
4. MacKellar DA, Valleroy LA, Secura GM, et al. Perceptions of lifetime risk and actual risk for acquiring HIV among young men who have sex with men. AIDS Behav 2007;11:263-270.
5. James NJ, Gillies PA, Bignell CJ. AIDS-related risk perception and sexual behaviour among sexually transmitted disease clinic attenders. Int J STD AIDS 1991;2:264-271.
6. Subbarao S, Otten RA, Ramos A, et al. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis 2006;194:904-911. (Pubitemid 44454075)
7. Peterson L, Taylor D, Roddy R, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007;2:e27.
8. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-1174.
9. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-2599.
10. Baeten J. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: The Partners PrEP study. HIV-1-infected adults [Abstract MOAX0106]. In: 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Rome: July 17-20, 2011.
11. Thigpen MC, Kebaabetswe PM, Smith DK, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study. HIV-1-infected adults [Abstract WELBC01]. In the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Rome: July 17-20, 2011.
12. Khawcharoenporn T, Kendrick S, Smith K. Does HIV risk perception affect condom use and pre-exposure prophylaxis (PrEP) interest? An examination of sexually transmitted infection clinic attendees and Black Gay Pride Event participants [Abstract 656]. In: 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Rome: July 17-20, 2011. Rome, Italy.
13. Gallo P, Colucci A, Camoni L, Regine V, Luzi AM, Suligoi B. Social and behavioural characteristics of a sample of AIDS Help-Line users never tested for HIV in Italy. Eur J Public Health 2010 (in press).
14. Essien EJ, Ogungbade GO, Ward D, et al. Influence of educational status and other variables on human immunodeficiency virus risk perception among military personnel: A large cohort finding. Mil Med 2007;172:1177-1181. (Pubitemid 350106154)
15. Whiteside YO, Harris T, Scanlon C, Clarkson S, Duffus W. Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina. AIDS Patient Care STDs 2011;25:365-370.
16. Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia. HIV Med 2010;11:282-288.
17. Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 2009; 50:77-83.
18. Adimora AA, Schoenbach VJ. Contextual factors and the black-white disparity in heterosexual HIV transmission. Epidemiology 2002;13:707-712. (Pubitemid 44698476)
19. Brown EJ, Outlaw FH, Simpson EM. Theoretical antecedent to HIV risk perception. J Am Psychiatr Nurses Assoc 2000; 6:177-182.
20. MacKellar DA, Valleroy LA, Secura GM, et al. Perceptions of lifetime risk and actual risk for acquiring HIV among young men who have sex with men. AIDS Behav 2007;11:263-270.
21. Magnus M, Kuo I, Shelley K, et al. Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. AIDS 2009;23:1277-1284.
22. Mehrotra P, Noar SM, Zimmerman RS, Palmgreen P. Demographic and personality factors as predictors of HIV/STD partner-specific risk perceptions: implications for interventions. AIDS Educ Prev 2009;21:39-54.
23. Barden-O'Fallon JL, deGraft-Johnson J, Bisika T, Sulzbach S, Benson A, Tsui AO. Factors associated with HIV/AIDS knowledge and risk perception in rural Malawi. AIDS Behav 2004;8:131-140. (Pubitemid 38888107)
24. Sarker M, Milkowski A, Slanger T, et al. The role of HIVrelated knowledge and ethnicity in determining HIV risk perception and willingness to undergo HIV testing among rural women in Burkina Faso. AIDS Behav 2005;9:243-249. (Pubitemid 40884226)
25. Stringer EM, Sinkala M, Kumwenda R, et al. Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. J Acquir Immune Defic Syndr 2004;35:60-66. (Pubitemid 38044784)
26. Prata N, Morris L, Mazive E, Vahidnia F, Stehr M. Relationship between HIV risk perception and condom use: Evidence from a population-based survey in Mozambique. Int Fam Plan Perspect 2006;32:192-200.
27. Lama JR, Guanira J, Goicochea, et al. Willingness to participate in a HIV pre-exposure prophylaxis efficacy trial among high risk men who have sex with men in the Andean region [Abstract MOPEC038]. In: 4th International AIDS Society Conference. Sydney, Australia: 2007.
28. Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 2010;54:548-555.
29. Liu AY, Kittredge PV, Vittinghoff E, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr 2008;47:241-247. (Pubitemid 351172193)
30. Barash EA, Golden M. Awareness and use of HIV pre-exposure prophylaxis among attendees of a seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDs 2010;24:689-691.
31. Centers for Disease Control and Prevention. Interim Guidance: Pre-exposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep 2011;60:65-68.
32. Michael NL. Oral pre-exposure prophylaxis for HIV - another arrow in the quiver? N Engl J Med 2010;363:2663-2665.
33. Kim SC, Becker S, Dieffenbach C, et al. Planning for preexposure prophylaxis to prevent HIV transmission: challenges and opportunities. J Int AIDS Soc 2010;13:24.
34. Myers GM, Mayer KH. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. AIDS Patient Care STDs 2011;25:63-71.